nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A3—germ cell cancer	0.586	1	CbGaD
Procainamide—SLC22A5—Dactinomycin—germ cell cancer	0.072	0.348	CbGbCtD
Procainamide—SLC22A2—Vinblastine—germ cell cancer	0.043	0.208	CbGbCtD
Procainamide—BCHE—Cisplatin—germ cell cancer	0.0413	0.2	CbGbCtD
Procainamide—SLC22A2—Cisplatin—germ cell cancer	0.0394	0.191	CbGbCtD
Procainamide—CYP2D6—Vinblastine—germ cell cancer	0.0108	0.0522	CbGbCtD
Procainamide—SCN3A—spinal nerve—germ cell cancer	0.00631	0.0845	CbGeAlD
Procainamide—SLC22A4—Organic cation transport—SLC22A3—germ cell cancer	0.00426	0.0547	CbGpPWpGaD
Procainamide—SLC22A5—Organic cation transport—SLC22A3—germ cell cancer	0.0032	0.0411	CbGpPWpGaD
Procainamide—DNMT1—Trans-sulfuration and one carbon metabolism—DNMT3L—germ cell cancer	0.00301	0.0387	CbGpPWpGaD
Procainamide—SLC22A2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00293	0.0377	CbGpPWpGaD
Procainamide—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00289	0.0371	CbGpPWpGaD
Procainamide—SLC22A1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00273	0.0351	CbGpPWpGaD
Procainamide—SCN11A—ganglion—germ cell cancer	0.0026	0.0348	CbGeAlD
Procainamide—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00217	0.0279	CbGpPWpGaD
Procainamide—SCN5A—Cardiac Progenitor Differentiation—ZFP42—germ cell cancer	0.00208	0.0267	CbGpPWpGaD
Procainamide—SLC22A2—Organic cation transport—SLC22A3—germ cell cancer	0.00201	0.0259	CbGpPWpGaD
Procainamide—SLC22A1—Organic cation transport—SLC22A3—germ cell cancer	0.00188	0.0241	CbGpPWpGaD
Procainamide—DNMT1—DNA methylation—DNMT3L—germ cell cancer	0.00178	0.0228	CbGpPWpGaD
Procainamide—SLC22A2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00168	0.0216	CbGpPWpGaD
Procainamide—Pericarditis—Ifosfamide—germ cell cancer	0.00162	0.0295	CcSEcCtD
Procainamide—SLC22A1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00157	0.0202	CbGpPWpGaD
Procainamide—ACHE—Synthesis, secretion, and deacylation of Ghrelin—KLF4—germ cell cancer	0.00156	0.02	CbGpPWpGaD
Procainamide—BCHE—Synthesis, secretion, and deacylation of Ghrelin—KLF4—germ cell cancer	0.00139	0.0179	CbGpPWpGaD
Procainamide—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00137	0.0175	CbGpPWpGaD
Procainamide—SCN10A—ganglion—germ cell cancer	0.00132	0.0176	CbGeAlD
Procainamide—SCN11A—trigeminal ganglion—germ cell cancer	0.00127	0.0171	CbGeAlD
Procainamide—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00127	0.0163	CbGpPWpGaD
Procainamide—SCN5A—Cardiac Progenitor Differentiation—SOX17—germ cell cancer	0.00114	0.0146	CbGpPWpGaD
Procainamide—SCN5A—Cardiac Progenitor Differentiation—NANOG—germ cell cancer	0.00109	0.014	CbGpPWpGaD
Procainamide—SCN7A—trigeminal ganglion—germ cell cancer	0.00108	0.0145	CbGeAlD
Procainamide—Hepatomegaly—Dactinomycin—germ cell cancer	0.00108	0.0197	CcSEcCtD
Procainamide—SCN5A—Cardiac Progenitor Differentiation—POU5F1—germ cell cancer	0.00105	0.0135	CbGpPWpGaD
Procainamide—DNMT1—Epigenetic regulation of gene expression—DNMT3L—germ cell cancer	0.00103	0.0133	CbGpPWpGaD
Procainamide—SLC22A1—ganglion—germ cell cancer	0.001	0.0134	CbGeAlD
Procainamide—Pleural effusion—Ifosfamide—germ cell cancer	0.000915	0.0167	CcSEcCtD
Procainamide—Ventricular fibrillation—Ifosfamide—germ cell cancer	0.000915	0.0167	CcSEcCtD
Procainamide—SCN8A—brainstem—germ cell cancer	0.000855	0.0115	CbGeAlD
Procainamide—SCN9A—trigeminal ganglion—germ cell cancer	0.000849	0.0114	CbGeAlD
Procainamide—DNMT1—trigeminal ganglion—germ cell cancer	0.000833	0.0112	CbGeAlD
Procainamide—DNMT1—embryo—germ cell cancer	0.000804	0.0108	CbGeAlD
Procainamide—ACHE—Monoamine Transport—PVRL2—germ cell cancer	0.000769	0.00988	CbGpPWpGaD
Procainamide—Pericarditis—Methotrexate—germ cell cancer	0.000766	0.014	CcSEcCtD
Procainamide—SCN8A—telencephalon—germ cell cancer	0.000759	0.0102	CbGeAlD
Procainamide—Vasculitis—Ifosfamide—germ cell cancer	0.000718	0.0131	CcSEcCtD
Procainamide—DNMT1—retina—germ cell cancer	0.000711	0.00953	CbGeAlD
Procainamide—SCN11A—spinal cord—germ cell cancer	0.000702	0.0094	CbGeAlD
Procainamide—Ventricular tachycardia—Ifosfamide—germ cell cancer	0.000701	0.0128	CcSEcCtD
Procainamide—SLC22A2—trigeminal ganglion—germ cell cancer	0.000695	0.00932	CbGeAlD
Procainamide—ACHE—trigeminal ganglion—germ cell cancer	0.000677	0.00907	CbGeAlD
Procainamide—CYP2D6—urine—germ cell cancer	0.000658	0.00882	CbGeAlD
Procainamide—DNMT1—telencephalon—germ cell cancer	0.000654	0.00877	CbGeAlD
Procainamide—SCN10A—trigeminal ganglion—germ cell cancer	0.000646	0.00866	CbGeAlD
Procainamide—SCN1A—brainstem—germ cell cancer	0.000646	0.00866	CbGeAlD
Procainamide—DNMT1—skin of body—germ cell cancer	0.000624	0.00837	CbGeAlD
Procainamide—SCN11A—head—germ cell cancer	0.000624	0.00836	CbGeAlD
Procainamide—DNMT1—DNA methylation—H2AFZ—germ cell cancer	0.000622	0.00798	CbGpPWpGaD
Procainamide—DNMT1—decidua—germ cell cancer	0.00062	0.00831	CbGeAlD
Procainamide—SCN7A—adrenal gland—germ cell cancer	0.000619	0.0083	CbGeAlD
Procainamide—Hepatic failure—Dactinomycin—germ cell cancer	0.000618	0.0113	CcSEcCtD
Procainamide—Arthritis—Bleomycin—germ cell cancer	0.000612	0.0112	CcSEcCtD
Procainamide—SLC22A4—neck—germ cell cancer	0.000597	0.00801	CbGeAlD
Procainamide—SCN2A—brainstem—germ cell cancer	0.000593	0.00795	CbGeAlD
Procainamide—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000587	0.00754	CbGpPWpGaD
Procainamide—SCN5A—Cardiac Progenitor Differentiation—SOX2—germ cell cancer	0.000583	0.00748	CbGpPWpGaD
Procainamide—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000578	0.00743	CbGpPWpGaD
Procainamide—SCN7A—female gonad—germ cell cancer	0.000577	0.00774	CbGeAlD
Procainamide—SCN1A—telencephalon—germ cell cancer	0.000574	0.00769	CbGeAlD
Procainamide—Lethargy—Dactinomycin—germ cell cancer	0.000566	0.0103	CcSEcCtD
Procainamide—Hepatic failure—Ifosfamide—germ cell cancer	0.000566	0.0103	CcSEcCtD
Procainamide—DNMT1—PRC2 methylates histones and DNA—H2AFZ—germ cell cancer	0.000564	0.00724	CbGpPWpGaD
Procainamide—Haemolytic anaemia—Ifosfamide—germ cell cancer	0.000563	0.0103	CcSEcCtD
Procainamide—SCN7A—Developmental Biology—TDGF1—germ cell cancer	0.000546	0.00702	CbGpPWpGaD
Procainamide—DNMT1—gonad—germ cell cancer	0.000546	0.00732	CbGeAlD
Procainamide—SCN9A—pituitary gland—germ cell cancer	0.000543	0.00728	CbGeAlD
Procainamide—DNMT1—uterus—germ cell cancer	0.000542	0.00727	CbGeAlD
Procainamide—Depression—Vinblastine—germ cell cancer	0.000541	0.00987	CcSEcCtD
Procainamide—SCN7A—endocrine gland—germ cell cancer	0.000537	0.0072	CbGeAlD
Procainamide—Atrial fibrillation—Ifosfamide—germ cell cancer	0.000537	0.00978	CcSEcCtD
Procainamide—Renal impairment—Ifosfamide—germ cell cancer	0.000534	0.00974	CcSEcCtD
Procainamide—DNMT1—pituitary gland—germ cell cancer	0.000533	0.00714	CbGeAlD
Procainamide—SCN8A—spinal cord—germ cell cancer	0.000532	0.00713	CbGeAlD
Procainamide—ACHE—telencephalon—germ cell cancer	0.000531	0.00712	CbGeAlD
Procainamide—SCN7A—head—germ cell cancer	0.00053	0.00711	CbGeAlD
Procainamide—SCN2A—telencephalon—germ cell cancer	0.000527	0.00706	CbGeAlD
Procainamide—Cardiac failure—Ifosfamide—germ cell cancer	0.000521	0.0095	CcSEcCtD
Procainamide—DNMT1—medulla oblongata—germ cell cancer	0.000514	0.00689	CbGeAlD
Procainamide—SCN7A—testis—germ cell cancer	0.000512	0.00686	CbGeAlD
Procainamide—SCN10A—telencephalon—germ cell cancer	0.000508	0.00681	CbGeAlD
Procainamide—Agranulocytosis—Vinblastine—germ cell cancer	0.000507	0.00924	CcSEcCtD
Procainamide—Rash maculo-papular—Etoposide—germ cell cancer	0.000503	0.00917	CcSEcCtD
Procainamide—Psychotic disorder—Ifosfamide—germ cell cancer	0.000497	0.00905	CcSEcCtD
Procainamide—SCN11A—Developmental Biology—TDGF1—germ cell cancer	0.000487	0.00625	CbGpPWpGaD
Procainamide—Haemolytic anaemia—Cisplatin—germ cell cancer	0.000486	0.00885	CcSEcCtD
Procainamide—SCN9A—adrenal gland—germ cell cancer	0.000485	0.0065	CbGeAlD
Procainamide—SCN4A—pituitary gland—germ cell cancer	0.000484	0.00649	CbGeAlD
Procainamide—Cardiac arrest—Ifosfamide—germ cell cancer	0.000484	0.00882	CcSEcCtD
Procainamide—ACHE—Peptide hormone metabolism—INHA—germ cell cancer	0.000483	0.0062	CbGpPWpGaD
Procainamide—SCN9A—midbrain—germ cell cancer	0.000479	0.00642	CbGeAlD
Procainamide—SCN8A—endocrine gland—germ cell cancer	0.000479	0.00642	CbGeAlD
Procainamide—DNMT1—adrenal gland—germ cell cancer	0.000476	0.00638	CbGeAlD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000474	0.00609	CbGpPWpGaD
Procainamide—SCN8A—head—germ cell cancer	0.000473	0.00633	CbGeAlD
Procainamide—Sunitinib—KIT—germ cell cancer	0.000471	1	CrCbGaD
Procainamide—DNMT1—midbrain—germ cell cancer	0.00047	0.0063	CbGeAlD
Procainamide—SLC22A3—trigeminal ganglion—germ cell cancer	0.00047	0.00629	CbGeAlD
Procainamide—SCN9A—spinal cord—germ cell cancer	0.000467	0.00626	CbGeAlD
Procainamide—SCN7A—Developmental Biology—SALL4—germ cell cancer	0.000465	0.00597	CbGpPWpGaD
Procainamide—SCN3A—telencephalon—germ cell cancer	0.000463	0.0062	CbGeAlD
Procainamide—DNMT1—bone marrow—germ cell cancer	0.00046	0.00617	CbGeAlD
Procainamide—SCN5A—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.00046	0.00591	CbGpPWpGaD
Procainamide—DNMT1—spinal cord—germ cell cancer	0.000458	0.00614	CbGeAlD
Procainamide—SCN8A—testis—germ cell cancer	0.000456	0.00612	CbGeAlD
Procainamide—SLC22A3—embryo—germ cell cancer	0.000453	0.00608	CbGeAlD
Procainamide—SCN11A—brain—germ cell cancer	0.000452	0.00606	CbGeAlD
Procainamide—SCN1A—medulla oblongata—germ cell cancer	0.000451	0.00604	CbGeAlD
Procainamide—Neutropenia—Dactinomycin—germ cell cancer	0.000449	0.00818	CcSEcCtD
Procainamide—SCN7A—Developmental Biology—NANOG—germ cell cancer	0.000445	0.00572	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TDGF1—germ cell cancer	0.000445	0.00572	CbGpPWpGaD
Procainamide—DNMT1—female gonad—germ cell cancer	0.000444	0.00595	CbGeAlD
Procainamide—SCN5A—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000443	0.00569	CbGpPWpGaD
Procainamide—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000443	0.00569	CbGpPWpGaD
Procainamide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000441	0.00567	CbGpPWpGaD
Procainamide—SCN3A—decidua—germ cell cancer	0.000439	0.00588	CbGeAlD
Procainamide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000435	0.00558	CbGpPWpGaD
Procainamide—Pleural effusion—Methotrexate—germ cell cancer	0.000433	0.00789	CcSEcCtD
Procainamide—SCN4A—adrenal gland—germ cell cancer	0.000433	0.0058	CbGeAlD
Procainamide—BCHE—Peptide hormone metabolism—INHA—germ cell cancer	0.000431	0.00553	CbGpPWpGaD
Procainamide—ACHE—Peptide hormone metabolism—KLF4—germ cell cancer	0.00043	0.00553	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—POU5F1—germ cell cancer	0.000429	0.00551	CbGpPWpGaD
Procainamide—SCN2A—pituitary gland—germ cell cancer	0.000429	0.00575	CbGeAlD
Procainamide—SCN8A—cerebellum—germ cell cancer	0.000422	0.00565	CbGeAlD
Procainamide—ACHE—medulla oblongata—germ cell cancer	0.000417	0.0056	CbGeAlD
Procainamide—DNMT1—NoRC negatively regulates rRNA expression—H2AFZ—germ cell cancer	0.000417	0.00536	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—SALL4—germ cell cancer	0.000414	0.00532	CbGpPWpGaD
Procainamide—SCN2A—medulla oblongata—germ cell cancer	0.000414	0.00554	CbGeAlD
Procainamide—SCN10A—pituitary gland—germ cell cancer	0.000413	0.00554	CbGeAlD
Procainamide—DNMT1—endocrine gland—germ cell cancer	0.000413	0.00553	CbGeAlD
Procainamide—SCN1A—midbrain—germ cell cancer	0.000412	0.00552	CbGeAlD
Procainamide—Cardiac failure—Etoposide—germ cell cancer	0.000412	0.0075	CcSEcCtD
Procainamide—DNMT1—Negative epigenetic regulation of rRNA expression—H2AFZ—germ cell cancer	0.000408	0.00524	CbGpPWpGaD
Procainamide—DNMT1—head—germ cell cancer	0.000407	0.00546	CbGeAlD
Procainamide—SCN1A—spinal cord—germ cell cancer	0.000402	0.00539	CbGeAlD
Procainamide—SCN9A—testis—germ cell cancer	0.000401	0.00538	CbGeAlD
Procainamide—Agranulocytosis—Dactinomycin—germ cell cancer	0.000399	0.00728	CcSEcCtD
Procainamide—SCN11A—Developmental Biology—NANOG—germ cell cancer	0.000397	0.0051	CbGpPWpGaD
Procainamide—Ill-defined disorder—Vinblastine—germ cell cancer	0.000394	0.00718	CcSEcCtD
Procainamide—DNMT1—testis—germ cell cancer	0.000393	0.00527	CbGeAlD
Procainamide—CHRM2—telencephalon—germ cell cancer	0.000393	0.00526	CbGeAlD
Procainamide—ACHE—adrenal gland—germ cell cancer	0.000386	0.00518	CbGeAlD
Procainamide—SLC22A1—telencephalon—germ cell cancer	0.000386	0.00517	CbGeAlD
Procainamide—Renal failure—Ifosfamide—germ cell cancer	0.000385	0.00702	CcSEcCtD
Procainamide—SCN7A—brain—germ cell cancer	0.000384	0.00515	CbGeAlD
Procainamide—SLC22A4—decidua—germ cell cancer	0.000384	0.00515	CbGeAlD
Procainamide—BCHE—Peptide hormone metabolism—KLF4—germ cell cancer	0.000384	0.00493	CbGpPWpGaD
Procainamide—Malaise—Vinblastine—germ cell cancer	0.000383	0.00698	CcSEcCtD
Procainamide—SCN11A—Developmental Biology—POU5F1—germ cell cancer	0.000382	0.00491	CbGpPWpGaD
Procainamide—Flushing—Bleomycin—germ cell cancer	0.000382	0.00697	CcSEcCtD
Procainamide—Cardiac arrest—Etoposide—germ cell cancer	0.000382	0.00696	CcSEcCtD
Procainamide—ACHE—midbrain—germ cell cancer	0.000382	0.00511	CbGeAlD
Procainamide—SCN8A—Developmental Biology—SALL4—germ cell cancer	0.000379	0.00486	CbGpPWpGaD
Procainamide—SCN2A—midbrain—germ cell cancer	0.000378	0.00507	CbGeAlD
Procainamide—SCN3A—pituitary gland—germ cell cancer	0.000377	0.00505	CbGeAlD
Procainamide—ACHE—spinal cord—germ cell cancer	0.000372	0.00499	CbGeAlD
Procainamide—SCN7A—lymph node—germ cell cancer	0.000371	0.00498	CbGeAlD
Procainamide—SCN4A—head—germ cell cancer	0.00037	0.00497	CbGeAlD
Procainamide—Chills—Bleomycin—germ cell cancer	0.000369	0.00673	CcSEcCtD
Procainamide—SCN2A—spinal cord—germ cell cancer	0.000369	0.00494	CbGeAlD
Procainamide—Convulsion—Vinblastine—germ cell cancer	0.000368	0.0067	CcSEcCtD
Procainamide—Agranulocytosis—Ifosfamide—germ cell cancer	0.000366	0.00667	CcSEcCtD
Procainamide—SCN3A—medulla oblongata—germ cell cancer	0.000364	0.00487	CbGeAlD
Procainamide—DNMT1—cerebellum—germ cell cancer	0.000363	0.00487	CbGeAlD
Procainamide—Abdominal discomfort—Cisplatin—germ cell cancer	0.000363	0.00662	CcSEcCtD
Procainamide—SCN8A—Developmental Biology—NANOG—germ cell cancer	0.000363	0.00466	CbGpPWpGaD
Procainamide—DNMT1—Epigenetic regulation of gene expression—H2AFZ—germ cell cancer	0.000362	0.00464	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TDGF1—germ cell cancer	0.00036	0.00463	CbGpPWpGaD
Procainamide—Oliguria—Methotrexate—germ cell cancer	0.00036	0.00656	CcSEcCtD
Procainamide—Bradycardia—Ifosfamide—germ cell cancer	0.000358	0.00653	CcSEcCtD
Procainamide—SCN4A—testis—germ cell cancer	0.000358	0.0048	CbGeAlD
Procainamide—SCN1A—head—germ cell cancer	0.000357	0.00479	CbGeAlD
Procainamide—Discomfort—Vinblastine—germ cell cancer	0.000357	0.00651	CcSEcCtD
Procainamide—Flushing—Dactinomycin—germ cell cancer	0.000356	0.0065	CcSEcCtD
Procainamide—SCN10A—spinal cord—germ cell cancer	0.000356	0.00477	CbGeAlD
Procainamide—Hepatic enzyme increased—Methotrexate—germ cell cancer	0.00035	0.00639	CcSEcCtD
Procainamide—Hallucination—Ifosfamide—germ cell cancer	0.00035	0.00638	CcSEcCtD
Procainamide—SCN8A—Developmental Biology—POU5F1—germ cell cancer	0.00035	0.00449	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TDGF1—germ cell cancer	0.000345	0.00443	CbGpPWpGaD
Procainamide—Chills—Dactinomycin—germ cell cancer	0.000345	0.00628	CcSEcCtD
Procainamide—SCN8A—brain—germ cell cancer	0.000342	0.00459	CbGeAlD
Procainamide—SLC22A5—trigeminal ganglion—germ cell cancer	0.000341	0.00458	CbGeAlD
Procainamide—Vasculitis—Methotrexate—germ cell cancer	0.00034	0.00619	CcSEcCtD
Procainamide—Thrombocytopenia—Vinblastine—germ cell cancer	0.000339	0.00618	CcSEcCtD
Procainamide—SCN7A—Developmental Biology—KLF4—germ cell cancer	0.000338	0.00434	CbGpPWpGaD
Procainamide—SCN3A—adrenal gland—germ cell cancer	0.000337	0.00451	CbGeAlD
Procainamide—Ill-defined disorder—Bleomycin—germ cell cancer	0.000333	0.00606	CcSEcCtD
Procainamide—BCHE—trigeminal ganglion—germ cell cancer	0.000333	0.00446	CbGeAlD
Procainamide—SCN3A—midbrain—germ cell cancer	0.000332	0.00445	CbGeAlD
Procainamide—Renal failure—Cisplatin—germ cell cancer	0.000332	0.00605	CcSEcCtD
Procainamide—SCN2A—endocrine gland—germ cell cancer	0.000332	0.00445	CbGeAlD
Procainamide—SCN2A—Developmental Biology—TDGF1—germ cell cancer	0.000331	0.00425	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TDGF1—germ cell cancer	0.000331	0.00425	CbGpPWpGaD
Procainamide—Anorexia—Vinblastine—germ cell cancer	0.00033	0.00602	CcSEcCtD
Procainamide—SLC22A4—pituitary gland—germ cell cancer	0.00033	0.00442	CbGeAlD
Procainamide—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.000328	0.00422	CbGpPWpGaD
Procainamide—SCN2A—head—germ cell cancer	0.000328	0.00439	CbGeAlD
Procainamide—Flushing—Ifosfamide—germ cell cancer	0.000327	0.00595	CcSEcCtD
Procainamide—Cardiac disorder—Ifosfamide—germ cell cancer	0.000327	0.00595	CcSEcCtD
Procainamide—SCN3A—bone marrow—germ cell cancer	0.000326	0.00436	CbGeAlD
Procainamide—Neutropenia—Etoposide—germ cell cancer	0.000325	0.00592	CcSEcCtD
Procainamide—SCN3A—spinal cord—germ cell cancer	0.000324	0.00435	CbGeAlD
Procainamide—Malaise—Bleomycin—germ cell cancer	0.000323	0.00589	CcSEcCtD
Procainamide—SCN10A—endocrine gland—germ cell cancer	0.00032	0.00429	CbGeAlD
Procainamide—ACHE—testis—germ cell cancer	0.00032	0.00428	CbGeAlD
Procainamide—SCN1A—Developmental Biology—TDGF1—germ cell cancer	0.000319	0.0041	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TDGF1—germ cell cancer	0.000319	0.0041	CbGpPWpGaD
Procainamide—SCN1A—cerebellum—germ cell cancer	0.000319	0.00427	CbGeAlD
Procainamide—SCN10A—head—germ cell cancer	0.000316	0.00424	CbGeAlD
Procainamide—Chills—Ifosfamide—germ cell cancer	0.000316	0.00576	CcSEcCtD
Procainamide—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00031	0.00565	CcSEcCtD
Procainamide—Bradycardia—Cisplatin—germ cell cancer	0.000309	0.00563	CcSEcCtD
Procainamide—SLC22A3—gonad—germ cell cancer	0.000308	0.00413	CbGeAlD
Procainamide—SCN9A—Developmental Biology—SALL4—germ cell cancer	0.000306	0.00393	CbGpPWpGaD
Procainamide—Myalgia—Bleomycin—germ cell cancer	0.000305	0.00556	CcSEcCtD
Procainamide—Renal failure—Etoposide—germ cell cancer	0.000304	0.00555	CcSEcCtD
Procainamide—Discomfort—Bleomycin—germ cell cancer	0.000301	0.0055	CcSEcCtD
Procainamide—Malaise—Dactinomycin—germ cell cancer	0.000301	0.00549	CcSEcCtD
Procainamide—Decreased appetite—Vinblastine—germ cell cancer	0.000301	0.00549	CcSEcCtD
Procainamide—SCN9A—brain—germ cell cancer	0.000301	0.00403	CbGeAlD
Procainamide—SCN11A—Developmental Biology—KLF4—germ cell cancer	0.000301	0.00386	CbGpPWpGaD
Procainamide—ACHE—cerebellum—germ cell cancer	0.000295	0.00396	CbGeAlD
Procainamide—DNMT1—brain—germ cell cancer	0.000295	0.00396	CbGeAlD
Procainamide—Confusional state—Bleomycin—germ cell cancer	0.000295	0.00538	CcSEcCtD
Procainamide—SLC22A4—adrenal gland—germ cell cancer	0.000295	0.00395	CbGeAlD
Procainamide—BCHE—brainstem—germ cell cancer	0.000294	0.00394	CbGeAlD
Procainamide—SCN9A—Developmental Biology—NANOG—germ cell cancer	0.000294	0.00377	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—SALL4—germ cell cancer	0.000293	0.00376	CbGpPWpGaD
Procainamide—SCN2A—cerebellum—germ cell cancer	0.000293	0.00392	CbGeAlD
Procainamide—SLC22A5—retina—germ cell cancer	0.000291	0.00391	CbGeAlD
Procainamide—SCN9A—lymph node—germ cell cancer	0.000291	0.0039	CbGeAlD
Procainamide—Agranulocytosis—Etoposide—germ cell cancer	0.000289	0.00527	CcSEcCtD
Procainamide—SCN3A—head—germ cell cancer	0.000288	0.00386	CbGeAlD
Procainamide—SCN5A—head—germ cell cancer	0.000287	0.00385	CbGeAlD
Procainamide—Thrombocytopenia—Bleomycin—germ cell cancer	0.000286	0.00522	CcSEcCtD
Procainamide—Feeling abnormal—Vinblastine—germ cell cancer	0.000285	0.0052	CcSEcCtD
Procainamide—DNMT1—lymph node—germ cell cancer	0.000285	0.00382	CbGeAlD
Procainamide—SLC22A4—bone marrow—germ cell cancer	0.000285	0.00382	CbGeAlD
Procainamide—Myalgia—Dactinomycin—germ cell cancer	0.000285	0.00519	CcSEcCtD
Procainamide—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000284	0.00518	CcSEcCtD
Procainamide—SLC22A4—spinal cord—germ cell cancer	0.000284	0.00381	CbGeAlD
Procainamide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000283	0.00516	CcSEcCtD
Procainamide—SCN9A—Developmental Biology—POU5F1—germ cell cancer	0.000283	0.00363	CbGpPWpGaD
Procainamide—Cardiac disorder—Cisplatin—germ cell cancer	0.000282	0.00513	CcSEcCtD
Procainamide—Flushing—Cisplatin—germ cell cancer	0.000282	0.00513	CcSEcCtD
Procainamide—SCN4A—Developmental Biology—SALL4—germ cell cancer	0.000281	0.00362	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—SALL4—germ cell cancer	0.000281	0.00362	CbGpPWpGaD
Procainamide—Discomfort—Dactinomycin—germ cell cancer	0.000281	0.00513	CcSEcCtD
Procainamide—SCN3A—Developmental Biology—NANOG—germ cell cancer	0.000281	0.00361	CbGpPWpGaD
Procainamide—Angioedema—Ifosfamide—germ cell cancer	0.00028	0.0051	CcSEcCtD
Procainamide—Anorexia—Bleomycin—germ cell cancer	0.000279	0.00508	CcSEcCtD
Procainamide—SCN3A—testis—germ cell cancer	0.000278	0.00373	CbGeAlD
Procainamide—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000278	0.00357	CbGpPWpGaD
Procainamide—Malaise—Ifosfamide—germ cell cancer	0.000276	0.00504	CcSEcCtD
Procainamide—SCN8A—Developmental Biology—KLF4—germ cell cancer	0.000275	0.00353	CbGpPWpGaD
Procainamide—Abdominal pain—Vinblastine—germ cell cancer	0.000274	0.00499	CcSEcCtD
Procainamide—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000274	0.00351	CbGpPWpGaD
Procainamide—Hypotension—Bleomycin—germ cell cancer	0.000273	0.00498	CcSEcCtD
Procainamide—SCN1A—Developmental Biology—SALL4—germ cell cancer	0.000271	0.00349	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—SALL4—germ cell cancer	0.000271	0.00349	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—POU5F1—germ cell cancer	0.00027	0.00347	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—NANOG—germ cell cancer	0.00027	0.00347	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—NANOG—germ cell cancer	0.00027	0.00347	CbGpPWpGaD
Procainamide—SCN4A—brain—germ cell cancer	0.000268	0.0036	CbGeAlD
Procainamide—SLC22A3—adrenal gland—germ cell cancer	0.000268	0.0036	CbGeAlD
Procainamide—Hepatic failure—Methotrexate—germ cell cancer	0.000268	0.00488	CcSEcCtD
Procainamide—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000267	0.00487	CcSEcCtD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000267	0.00343	CbGpPWpGaD
Procainamide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000267	0.00486	CcSEcCtD
Procainamide—Convulsion—Ifosfamide—germ cell cancer	0.000265	0.00484	CcSEcCtD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000263	0.00338	CbGpPWpGaD
Procainamide—BCHE—telencephalon—germ cell cancer	0.000261	0.0035	CbGeAlD
Procainamide—Myalgia—Ifosfamide—germ cell cancer	0.000261	0.00475	CcSEcCtD
Procainamide—Arthralgia—Ifosfamide—germ cell cancer	0.000261	0.00475	CcSEcCtD
Procainamide—SCN1A—Developmental Biology—NANOG—germ cell cancer	0.00026	0.00334	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—NANOG—germ cell cancer	0.00026	0.00334	CbGpPWpGaD
Procainamide—Anorexia—Dactinomycin—germ cell cancer	0.00026	0.00474	CcSEcCtD
Procainamide—SCN4A—Developmental Biology—POU5F1—germ cell cancer	0.00026	0.00334	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—POU5F1—germ cell cancer	0.00026	0.00334	CbGpPWpGaD
Procainamide—SCN1A—brain—germ cell cancer	0.000259	0.00347	CbGeAlD
Procainamide—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000259	0.00332	CbGpPWpGaD
Procainamide—Cardiac disorder—Etoposide—germ cell cancer	0.000258	0.0047	CcSEcCtD
Procainamide—Flushing—Etoposide—germ cell cancer	0.000258	0.0047	CcSEcCtD
Procainamide—Discomfort—Ifosfamide—germ cell cancer	0.000258	0.0047	CcSEcCtD
Procainamide—SCN3A—cerebellum—germ cell cancer	0.000257	0.00345	CbGeAlD
Procainamide—SLC22A5—skin of body—germ cell cancer	0.000256	0.00343	CbGeAlD
Procainamide—Hypersensitivity—Vinblastine—germ cell cancer	0.000255	0.00465	CcSEcCtD
Procainamide—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000255	0.00327	CbGpPWpGaD
Procainamide—Decreased appetite—Bleomycin—germ cell cancer	0.000254	0.00464	CcSEcCtD
Procainamide—Confusional state—Ifosfamide—germ cell cancer	0.000252	0.00459	CcSEcCtD
Procainamide—SCN10A—Developmental Biology—POU5F1—germ cell cancer	0.00025	0.00322	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—POU5F1—germ cell cancer	0.00025	0.00322	CbGpPWpGaD
Procainamide—SLC22A3—female gonad—germ cell cancer	0.00025	0.00335	CbGeAlD
Procainamide—Chills—Etoposide—germ cell cancer	0.000249	0.00455	CcSEcCtD
Procainamide—BCHE—skin of body—germ cell cancer	0.000249	0.00334	CbGeAlD
Procainamide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000249	0.00453	CcSEcCtD
Procainamide—Asthenia—Vinblastine—germ cell cancer	0.000248	0.00453	CcSEcCtD
Procainamide—CHRM2—endocrine gland—germ cell cancer	0.000248	0.00332	CbGeAlD
Procainamide—SCN5A—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000246	0.00315	CbGpPWpGaD
Procainamide—Lethargy—Methotrexate—germ cell cancer	0.000246	0.00448	CcSEcCtD
Procainamide—Ill-defined disorder—Cisplatin—germ cell cancer	0.000245	0.00447	CcSEcCtD
Procainamide—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000245	0.00446	CcSEcCtD
Procainamide—CHRM2—head—germ cell cancer	0.000245	0.00328	CbGeAlD
Procainamide—SLC22A1—endocrine gland—germ cell cancer	0.000243	0.00326	CbGeAlD
Procainamide—Feeling abnormal—Bleomycin—germ cell cancer	0.000241	0.00439	CcSEcCtD
Procainamide—SLC22A1—head—germ cell cancer	0.00024	0.00322	CbGeAlD
Procainamide—ACHE—brain—germ cell cancer	0.00024	0.00321	CbGeAlD
Procainamide—SCN5A—Cardiac Progenitor Differentiation—KIT—germ cell cancer	0.00024	0.00308	CbGpPWpGaD
Procainamide—Anorexia—Ifosfamide—germ cell cancer	0.000238	0.00434	CcSEcCtD
Procainamide—Malaise—Cisplatin—germ cell cancer	0.000238	0.00434	CcSEcCtD
Procainamide—SCN7A—Developmental Biology—SOX2—germ cell cancer	0.000238	0.00305	CbGpPWpGaD
Procainamide—SCN2A—brain—germ cell cancer	0.000238	0.00318	CbGeAlD
Procainamide—CHRM2—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000237	0.00305	CbGpPWpGaD
Procainamide—Decreased appetite—Dactinomycin—germ cell cancer	0.000237	0.00432	CcSEcCtD
Procainamide—Diarrhoea—Vinblastine—germ cell cancer	0.000237	0.00432	CcSEcCtD
Procainamide—Dysgeusia—Etoposide—germ cell cancer	0.000237	0.00432	CcSEcCtD
Procainamide—Hypotension—Ifosfamide—germ cell cancer	0.000234	0.00426	CcSEcCtD
Procainamide—SLC22A3—endocrine gland—germ cell cancer	0.000233	0.00312	CbGeAlD
Procainamide—Urticaria—Bleomycin—germ cell cancer	0.000232	0.00424	CcSEcCtD
Procainamide—ACHE—lymph node—germ cell cancer	0.000232	0.00311	CbGeAlD
Procainamide—Body temperature increased—Bleomycin—germ cell cancer	0.000231	0.00422	CcSEcCtD
Procainamide—SLC22A3—head—germ cell cancer	0.00023	0.00308	CbGeAlD
Procainamide—SCN10A—brain—germ cell cancer	0.000229	0.00307	CbGeAlD
Procainamide—Dizziness—Vinblastine—germ cell cancer	0.000229	0.00417	CcSEcCtD
Procainamide—Convulsion—Cisplatin—germ cell cancer	0.000229	0.00417	CcSEcCtD
Procainamide—CHRM2—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000228	0.00293	CbGpPWpGaD
Procainamide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000228	0.00415	CcSEcCtD
Procainamide—SLC22A4—cerebellum—germ cell cancer	0.000225	0.00302	CbGeAlD
Procainamide—Myalgia—Cisplatin—germ cell cancer	0.000225	0.0041	CcSEcCtD
Procainamide—Feeling abnormal—Dactinomycin—germ cell cancer	0.000225	0.0041	CcSEcCtD
Procainamide—Ill-defined disorder—Etoposide—germ cell cancer	0.000224	0.00409	CcSEcCtD
Procainamide—SCN5A—Developmental Biology—TDGF1—germ cell cancer	0.000224	0.00288	CbGpPWpGaD
Procainamide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000223	0.00407	CcSEcCtD
Procainamide—SCN9A—Developmental Biology—KLF4—germ cell cancer	0.000223	0.00286	CbGpPWpGaD
Procainamide—Discomfort—Cisplatin—germ cell cancer	0.000222	0.00405	CcSEcCtD
Procainamide—SLC22A3—testis—germ cell cancer	0.000222	0.00297	CbGeAlD
Procainamide—SCN10A—lymph node—germ cell cancer	0.000221	0.00297	CbGeAlD
Procainamide—Vomiting—Vinblastine—germ cell cancer	0.00022	0.00401	CcSEcCtD
Procainamide—SLC22A5—pituitary gland—germ cell cancer	0.000218	0.00293	CbGeAlD
Procainamide—Malaise—Etoposide—germ cell cancer	0.000218	0.00398	CcSEcCtD
Procainamide—Decreased appetite—Ifosfamide—germ cell cancer	0.000217	0.00396	CcSEcCtD
Procainamide—BCHE—uterus—germ cell cancer	0.000217	0.0029	CbGeAlD
Procainamide—Body temperature increased—Dactinomycin—germ cell cancer	0.000216	0.00393	CcSEcCtD
Procainamide—Abdominal pain—Dactinomycin—germ cell cancer	0.000216	0.00393	CcSEcCtD
Procainamide—Hypersensitivity—Bleomycin—germ cell cancer	0.000216	0.00393	CcSEcCtD
Procainamide—SCN3A—Developmental Biology—KLF4—germ cell cancer	0.000213	0.00273	CbGpPWpGaD
Procainamide—BCHE—pituitary gland—germ cell cancer	0.000213	0.00285	CbGeAlD
Procainamide—SCN11A—Developmental Biology—SOX2—germ cell cancer	0.000212	0.00272	CbGpPWpGaD
Procainamide—Thrombocytopenia—Cisplatin—germ cell cancer	0.000211	0.00385	CcSEcCtD
Procainamide—SLC22A5—medulla oblongata—germ cell cancer	0.000211	0.00282	CbGeAlD
Procainamide—Asthenia—Bleomycin—germ cell cancer	0.00021	0.00383	CcSEcCtD
Procainamide—Convulsion—Etoposide—germ cell cancer	0.00021	0.00382	CcSEcCtD
Procainamide—SCN3A—brain—germ cell cancer	0.000209	0.0028	CbGeAlD
Procainamide—SCN5A—brain—germ cell cancer	0.000208	0.00279	CbGeAlD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000207	0.00266	CbGpPWpGaD
Procainamide—Pruritus—Bleomycin—germ cell cancer	0.000207	0.00377	CcSEcCtD
Procainamide—Feeling abnormal—Ifosfamide—germ cell cancer	0.000206	0.00376	CcSEcCtD
Procainamide—Eosinophilia—Methotrexate—germ cell cancer	0.000206	0.00375	CcSEcCtD
Procainamide—Nausea—Vinblastine—germ cell cancer	0.000206	0.00375	CcSEcCtD
Procainamide—Anorexia—Cisplatin—germ cell cancer	0.000205	0.00374	CcSEcCtD
Procainamide—BCHE—medulla oblongata—germ cell cancer	0.000205	0.00275	CbGeAlD
Procainamide—SCN4A—Developmental Biology—KLF4—germ cell cancer	0.000205	0.00263	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—KLF4—germ cell cancer	0.000205	0.00263	CbGpPWpGaD
Procainamide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000204	0.00373	CcSEcCtD
Procainamide—Discomfort—Etoposide—germ cell cancer	0.000204	0.00371	CcSEcCtD
Procainamide—SCN3A—lymph node—germ cell cancer	0.000202	0.0027	CbGeAlD
Procainamide—Hypotension—Cisplatin—germ cell cancer	0.000201	0.00367	CcSEcCtD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000201	0.00258	CbGpPWpGaD
Procainamide—Hypersensitivity—Dactinomycin—germ cell cancer	0.000201	0.00366	CcSEcCtD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000201	0.00258	CbGpPWpGaD
Procainamide—Abdominal discomfort—Methotrexate—germ cell cancer	0.000199	0.00363	CcSEcCtD
Procainamide—DNMT1—Gene Expression—NR0B1—germ cell cancer	0.000199	0.00256	CbGpPWpGaD
Procainamide—Confusional state—Etoposide—germ cell cancer	0.000199	0.00363	CcSEcCtD
Procainamide—Urticaria—Ifosfamide—germ cell cancer	0.000199	0.00362	CcSEcCtD
Procainamide—Abdominal pain—Ifosfamide—germ cell cancer	0.000198	0.0036	CcSEcCtD
Procainamide—Body temperature increased—Ifosfamide—germ cell cancer	0.000198	0.0036	CcSEcCtD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000198	0.00254	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—KLF4—germ cell cancer	0.000197	0.00253	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—KLF4—germ cell cancer	0.000197	0.00253	CbGpPWpGaD
Procainamide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000196	0.00358	CcSEcCtD
Procainamide—Asthenia—Dactinomycin—germ cell cancer	0.000196	0.00357	CcSEcCtD
Procainamide—SLC22A5—adrenal gland—germ cell cancer	0.000195	0.00261	CbGeAlD
Procainamide—CYP2D6—brainstem—germ cell cancer	0.000195	0.00261	CbGeAlD
Procainamide—Neutropenia—Methotrexate—germ cell cancer	0.000194	0.00354	CcSEcCtD
Procainamide—SCN8A—Developmental Biology—SOX2—germ cell cancer	0.000194	0.00249	CbGpPWpGaD
Procainamide—Thrombocytopenia—Etoposide—germ cell cancer	0.000193	0.00352	CcSEcCtD
Procainamide—SLC22A5—midbrain—germ cell cancer	0.000193	0.00258	CbGeAlD
Procainamide—SCN5A—Developmental Biology—SALL4—germ cell cancer	0.000191	0.00245	CbGpPWpGaD
Procainamide—BCHE—adrenal gland—germ cell cancer	0.00019	0.00255	CbGeAlD
Procainamide—Anorexia—Etoposide—germ cell cancer	0.000188	0.00343	CcSEcCtD
Procainamide—SLC22A5—spinal cord—germ cell cancer	0.000188	0.00252	CbGeAlD
Procainamide—BCHE—midbrain—germ cell cancer	0.000188	0.00251	CbGeAlD
Procainamide—Decreased appetite—Cisplatin—germ cell cancer	0.000187	0.00342	CcSEcCtD
Procainamide—Diarrhoea—Dactinomycin—germ cell cancer	0.000187	0.0034	CcSEcCtD
Procainamide—Vomiting—Bleomycin—germ cell cancer	0.000186	0.00339	CcSEcCtD
Procainamide—Depression—Methotrexate—germ cell cancer	0.000185	0.00337	CcSEcCtD
Procainamide—Hypotension—Etoposide—germ cell cancer	0.000185	0.00336	CcSEcCtD
Procainamide—Hypersensitivity—Ifosfamide—germ cell cancer	0.000184	0.00336	CcSEcCtD
Procainamide—BCHE—bone marrow—germ cell cancer	0.000184	0.00246	CbGeAlD
Procainamide—BCHE—spinal cord—germ cell cancer	0.000183	0.00245	CbGeAlD
Procainamide—SCN5A—Developmental Biology—NANOG—germ cell cancer	0.000183	0.00235	CbGpPWpGaD
Procainamide—SLC22A4—brain—germ cell cancer	0.000183	0.00245	CbGeAlD
Procainamide—Renal failure—Methotrexate—germ cell cancer	0.000182	0.00332	CcSEcCtD
Procainamide—SLC22A5—female gonad—germ cell cancer	0.000182	0.00244	CbGeAlD
Procainamide—Asthenia—Ifosfamide—germ cell cancer	0.000179	0.00327	CcSEcCtD
Procainamide—Feeling abnormal—Cisplatin—germ cell cancer	0.000178	0.00324	CcSEcCtD
Procainamide—CHRM2—brain—germ cell cancer	0.000177	0.00238	CbGeAlD
Procainamide—Pruritus—Ifosfamide—germ cell cancer	0.000177	0.00322	CcSEcCtD
Procainamide—SLC22A4—lymph node—germ cell cancer	0.000177	0.00237	CbGeAlD
Procainamide—SCN5A—Developmental Biology—POU5F1—germ cell cancer	0.000176	0.00226	CbGpPWpGaD
Procainamide—SLC22A1—brain—germ cell cancer	0.000174	0.00233	CbGeAlD
Procainamide—Nausea—Bleomycin—germ cell cancer	0.000174	0.00317	CcSEcCtD
Procainamide—Vomiting—Dactinomycin—germ cell cancer	0.000173	0.00316	CcSEcCtD
Procainamide—Agranulocytosis—Methotrexate—germ cell cancer	0.000173	0.00315	CcSEcCtD
Procainamide—CYP2D6—telencephalon—germ cell cancer	0.000173	0.00232	CbGeAlD
Procainamide—DNMT1—Gene Expression—DNMT3L—germ cell cancer	0.000173	0.00222	CbGpPWpGaD
Procainamide—Decreased appetite—Etoposide—germ cell cancer	0.000172	0.00313	CcSEcCtD
Procainamide—Diarrhoea—Ifosfamide—germ cell cancer	0.000171	0.00312	CcSEcCtD
Procainamide—Body temperature increased—Cisplatin—germ cell cancer	0.00017	0.00311	CcSEcCtD
Procainamide—SLC22A3—brain—germ cell cancer	0.000166	0.00223	CbGeAlD
Procainamide—Dizziness—Ifosfamide—germ cell cancer	0.000165	0.00301	CcSEcCtD
Procainamide—BCHE—endocrine gland—germ cell cancer	0.000165	0.00221	CbGeAlD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	0.000164	0.0021	CbGpPWpGaD
Procainamide—Feeling abnormal—Etoposide—germ cell cancer	0.000163	0.00297	CcSEcCtD
Procainamide—BCHE—head—germ cell cancer	0.000163	0.00218	CbGeAlD
Procainamide—Nausea—Dactinomycin—germ cell cancer	0.000162	0.00295	CcSEcCtD
Procainamide—Gastrointestinal pain—Etoposide—germ cell cancer	0.000161	0.00294	CcSEcCtD
Procainamide—SLC22A5—testis—germ cell cancer	0.000161	0.00216	CbGeAlD
Procainamide—SLC22A3—lymph node—germ cell cancer	0.000161	0.00216	CbGeAlD
Procainamide—DNMT1—Gene Expression—RARS—germ cell cancer	0.000161	0.00206	CbGpPWpGaD
Procainamide—Vomiting—Ifosfamide—germ cell cancer	0.000159	0.0029	CcSEcCtD
Procainamide—Hypersensitivity—Cisplatin—germ cell cancer	0.000159	0.00289	CcSEcCtD
Procainamide—BCHE—testis—germ cell cancer	0.000157	0.00211	CbGeAlD
Procainamide—Urticaria—Etoposide—germ cell cancer	0.000157	0.00286	CcSEcCtD
Procainamide—SCN9A—Developmental Biology—SOX2—germ cell cancer	0.000157	0.00201	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000156	0.00201	CbGpPWpGaD
Procainamide—Body temperature increased—Etoposide—germ cell cancer	0.000156	0.00285	CcSEcCtD
Procainamide—Abdominal pain—Etoposide—germ cell cancer	0.000156	0.00285	CcSEcCtD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000156	0.002	CbGpPWpGaD
Procainamide—Asthenia—Cisplatin—germ cell cancer	0.000155	0.00282	CcSEcCtD
Procainamide—Cardiac disorder—Methotrexate—germ cell cancer	0.000154	0.00282	CcSEcCtD
Procainamide—SCN3A—Developmental Biology—SOX2—germ cell cancer	0.00015	0.00193	CbGpPWpGaD
Procainamide—Chills—Methotrexate—germ cell cancer	0.000149	0.00272	CcSEcCtD
Procainamide—SLC22A5—cerebellum—germ cell cancer	0.000149	0.002	CbGeAlD
Procainamide—Nausea—Ifosfamide—germ cell cancer	0.000148	0.00271	CcSEcCtD
Procainamide—Diarrhoea—Cisplatin—germ cell cancer	0.000147	0.00269	CcSEcCtD
Procainamide—Hypersensitivity—Etoposide—germ cell cancer	0.000145	0.00265	CcSEcCtD
Procainamide—BCHE—cerebellum—germ cell cancer	0.000145	0.00194	CbGeAlD
Procainamide—SCN5A—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000145	0.00186	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—SOX2—germ cell cancer	0.000144	0.00185	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—SOX2—germ cell cancer	0.000144	0.00185	CbGpPWpGaD
Procainamide—Dysgeusia—Methotrexate—germ cell cancer	0.000142	0.00259	CcSEcCtD
Procainamide—Asthenia—Etoposide—germ cell cancer	0.000142	0.00258	CcSEcCtD
Procainamide—Pruritus—Etoposide—germ cell cancer	0.00014	0.00255	CcSEcCtD
Procainamide—SCN10A—Developmental Biology—SOX2—germ cell cancer	0.000139	0.00178	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—SOX2—germ cell cancer	0.000139	0.00178	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—KLF4—germ cell cancer	0.000139	0.00178	CbGpPWpGaD
Procainamide—Vomiting—Cisplatin—germ cell cancer	0.000137	0.0025	CcSEcCtD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000136	0.00174	CbGpPWpGaD
Procainamide—Diarrhoea—Etoposide—germ cell cancer	0.000135	0.00246	CcSEcCtD
Procainamide—Ill-defined disorder—Methotrexate—germ cell cancer	0.000134	0.00245	CcSEcCtD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	0.000134	0.00173	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000134	0.00172	CbGpPWpGaD
Procainamide—Malaise—Methotrexate—germ cell cancer	0.000131	0.00238	CcSEcCtD
Procainamide—Dizziness—Etoposide—germ cell cancer	0.000131	0.00238	CcSEcCtD
Procainamide—Nausea—Cisplatin—germ cell cancer	0.000128	0.00233	CcSEcCtD
Procainamide—CHRM2—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000127	0.00163	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000126	0.00162	CbGpPWpGaD
Procainamide—Convulsion—Methotrexate—germ cell cancer	0.000126	0.00229	CcSEcCtD
Procainamide—Vomiting—Etoposide—germ cell cancer	0.000126	0.00229	CcSEcCtD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000124	0.0016	CbGpPWpGaD
Procainamide—Arthralgia—Methotrexate—germ cell cancer	0.000123	0.00225	CcSEcCtD
Procainamide—Myalgia—Methotrexate—germ cell cancer	0.000123	0.00225	CcSEcCtD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000123	0.00158	CbGpPWpGaD
Procainamide—Discomfort—Methotrexate—germ cell cancer	0.000122	0.00222	CcSEcCtD
Procainamide—SLC22A5—brain—germ cell cancer	0.000121	0.00162	CbGeAlD
Procainamide—Confusional state—Methotrexate—germ cell cancer	0.000119	0.00217	CcSEcCtD
Procainamide—BCHE—brain—germ cell cancer	0.000118	0.00158	CbGeAlD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000118	0.00151	CbGpPWpGaD
Procainamide—CYP2D6—female gonad—germ cell cancer	0.000117	0.00157	CbGeAlD
Procainamide—Nausea—Etoposide—germ cell cancer	0.000117	0.00214	CcSEcCtD
Procainamide—SLC22A5—lymph node—germ cell cancer	0.000117	0.00157	CbGeAlD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000116	0.00149	CbGpPWpGaD
Procainamide—Thrombocytopenia—Methotrexate—germ cell cancer	0.000116	0.00211	CcSEcCtD
Procainamide—BCHE—lymph node—germ cell cancer	0.000114	0.00153	CbGeAlD
Procainamide—Anorexia—Methotrexate—germ cell cancer	0.000113	0.00205	CcSEcCtD
Procainamide—Hypotension—Methotrexate—germ cell cancer	0.000111	0.00201	CcSEcCtD
Procainamide—CYP2D6—endocrine gland—germ cell cancer	0.000109	0.00146	CbGeAlD
Procainamide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000108	0.00196	CcSEcCtD
Procainamide—CYP2D6—head—germ cell cancer	0.000108	0.00144	CbGeAlD
Procainamide—CYP2D6—testis—germ cell cancer	0.000104	0.00139	CbGeAlD
Procainamide—Decreased appetite—Methotrexate—germ cell cancer	0.000103	0.00187	CcSEcCtD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000102	0.00131	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000102	0.00131	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.0001	0.00129	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	9.8e-05	0.00126	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—SOX2—germ cell cancer	9.77e-05	0.00125	CbGpPWpGaD
Procainamide—Feeling abnormal—Methotrexate—germ cell cancer	9.75e-05	0.00178	CcSEcCtD
Procainamide—Gastrointestinal pain—Methotrexate—germ cell cancer	9.67e-05	0.00176	CcSEcCtD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	9.65e-05	0.00124	CbGpPWpGaD
Procainamide—CYP2D6—cerebellum—germ cell cancer	9.61e-05	0.00129	CbGeAlD
Procainamide—Urticaria—Methotrexate—germ cell cancer	9.4e-05	0.00171	CcSEcCtD
Procainamide—Body temperature increased—Methotrexate—germ cell cancer	9.35e-05	0.0017	CcSEcCtD
Procainamide—Abdominal pain—Methotrexate—germ cell cancer	9.35e-05	0.0017	CcSEcCtD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—AVP—germ cell cancer	9.28e-05	0.00119	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—AVP—germ cell cancer	9.25e-05	0.00119	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	9.14e-05	0.00117	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—INHA—germ cell cancer	9.11e-05	0.00117	CbGpPWpGaD
Procainamide—Hypersensitivity—Methotrexate—germ cell cancer	8.71e-05	0.00159	CcSEcCtD
Procainamide—Asthenia—Methotrexate—germ cell cancer	8.49e-05	0.00155	CcSEcCtD
Procainamide—Pruritus—Methotrexate—germ cell cancer	8.37e-05	0.00153	CcSEcCtD
Procainamide—BCHE—Metabolism of proteins—INHA—germ cell cancer	8.13e-05	0.00104	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—KLF4—germ cell cancer	8.12e-05	0.00104	CbGpPWpGaD
Procainamide—Diarrhoea—Methotrexate—germ cell cancer	8.09e-05	0.00148	CcSEcCtD
Procainamide—Dizziness—Methotrexate—germ cell cancer	7.82e-05	0.00143	CcSEcCtD
Procainamide—CYP2D6—brain—germ cell cancer	7.81e-05	0.00105	CbGeAlD
Procainamide—Vomiting—Methotrexate—germ cell cancer	7.52e-05	0.00137	CcSEcCtD
Procainamide—CHRM2—SIDS Susceptibility Pathways—AVP—germ cell cancer	7.47e-05	0.000959	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—KLF4—germ cell cancer	7.25e-05	0.000931	CbGpPWpGaD
Procainamide—Nausea—Methotrexate—germ cell cancer	7.03e-05	0.00128	CcSEcCtD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	6.8e-05	0.000873	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.41e-05	0.000824	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	6.32e-05	0.000811	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—AVP—germ cell cancer	6.25e-05	0.000803	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	6.24e-05	0.000802	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	6.06e-05	0.000779	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—H2AFZ—germ cell cancer	6.04e-05	0.000776	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.98e-05	0.000768	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—HRAS—germ cell cancer	5.93e-05	0.000761	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	5.89e-05	0.000756	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.89e-05	0.000756	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	5.82e-05	0.000747	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	5.42e-05	0.000697	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—HRAS—germ cell cancer	5.28e-05	0.000678	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—HRAS—germ cell cancer	4.83e-05	0.00062	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—SLC2A3—germ cell cancer	4.79e-05	0.000615	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—OXT—germ cell cancer	4.75e-05	0.00061	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—AVP—germ cell cancer	4.72e-05	0.000606	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—AVP—germ cell cancer	4.7e-05	0.000604	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.28e-05	0.000549	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—HRAS—germ cell cancer	4.23e-05	0.000543	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—HRAS—germ cell cancer	3.91e-05	0.000502	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CRABP1—germ cell cancer	3.85e-05	0.000494	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SLC2A3—germ cell cancer	3.77e-05	0.000484	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—HRAS—germ cell cancer	3.77e-05	0.000484	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—HRAS—germ cell cancer	3.74e-05	0.00048	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SLC22A3—germ cell cancer	3.71e-05	0.000477	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	3.59e-05	0.000461	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—HRAS—germ cell cancer	3.59e-05	0.000461	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—HRAS—germ cell cancer	3.59e-05	0.000461	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—HRAS—germ cell cancer	3.46e-05	0.000445	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—HRAS—germ cell cancer	3.46e-05	0.000445	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—HRAS—germ cell cancer	3.45e-05	0.000443	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SLC2A3—germ cell cancer	3.36e-05	0.000432	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SLC22A3—germ cell cancer	3.31e-05	0.000425	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—AVP—germ cell cancer	3.26e-05	0.000418	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CRABP1—germ cell cancer	3.03e-05	0.000389	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SLC2A3—germ cell cancer	3e-05	0.000386	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SLC22A3—germ cell cancer	2.96e-05	0.00038	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—AVP—germ cell cancer	2.96e-05	0.00038	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.95e-05	0.000379	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SLC2A3—germ cell cancer	2.8e-05	0.00036	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—HRAS—germ cell cancer	2.79e-05	0.000358	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SLC22A3—germ cell cancer	2.76e-05	0.000354	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.76e-05	0.000354	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—HRAS—germ cell cancer	2.72e-05	0.000349	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CRABP1—germ cell cancer	2.7e-05	0.000347	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—OXT—germ cell cancer	2.69e-05	0.000345	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—HRAS—germ cell cancer	2.67e-05	0.000343	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—HRAS—germ cell cancer	2.56e-05	0.000329	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—HRAS—germ cell cancer	2.56e-05	0.000329	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—HRAS—germ cell cancer	2.47e-05	0.000317	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—HRAS—germ cell cancer	2.47e-05	0.000317	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—OXT—germ cell cancer	2.44e-05	0.000313	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—HRAS—germ cell cancer	2.43e-05	0.000313	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—HRAS—germ cell cancer	2.43e-05	0.000311	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CRABP1—germ cell cancer	2.41e-05	0.00031	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CRABP1—germ cell cancer	2.25e-05	0.000289	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—HRAS—germ cell cancer	2.17e-05	0.000278	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—MYC—germ cell cancer	2.09e-05	0.000268	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—HRAS—germ cell cancer	2.08e-05	0.000268	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—HRAS—germ cell cancer	2.02e-05	0.000259	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—HRAS—germ cell cancer	1.86e-05	0.000239	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AVP—germ cell cancer	1.84e-05	0.000236	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—HRAS—germ cell cancer	1.74e-05	0.000223	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AVP—germ cell cancer	1.67e-05	0.000215	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—HRAS—germ cell cancer	1.66e-05	0.000213	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—HRAS—germ cell cancer	1.55e-05	0.000199	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC2A3—germ cell cancer	1.55e-05	0.000199	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC22A3—germ cell cancer	1.52e-05	0.000196	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—OXT—germ cell cancer	1.44e-05	0.000185	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CRABP1—germ cell cancer	1.24e-05	0.000159	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGF4—germ cell cancer	1.23e-05	0.000158	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—H2AFZ—germ cell cancer	1.1e-05	0.000141	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KITLG—germ cell cancer	1.01e-05	0.00013	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AVP—germ cell cancer	9.88e-06	0.000127	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGFR3—germ cell cancer	7.51e-06	9.64e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KIT—germ cell cancer	6.89e-06	8.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HRAS—germ cell cancer	5.04e-06	6.48e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MYC—germ cell cancer	3.79e-06	4.87e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—germ cell cancer	3.12e-06	4e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HRAS—germ cell cancer	2.98e-06	3.83e-05	CbGpPWpGaD
